CClinicalTrials.gg
Not yet recruitingNCT07681180EASY-HDUpdated Jul 2, 2026

Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies

An interventional study of Auditive experience and Audiovisual immersive experience in Cardiovascular Disease, Cardiovascular Care and Pain and Anxiety During Cardiac Catheterization, sponsored by Olivier F. Bertrand. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-02.

Sponsored by Olivier F. Bertrand · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this prospective pilot study is to learn if the use of virtual reality and/or relaxing soundscapes can help lower anxiety in adult patients undergoing a scheduled coronary angiography or angioplasty as compared to the standard of care. The main questions it aims to answer are:

  • The use of non-pharmacological strategies reduces intraprocedural stress and anxiety compared to standard of care
  • Reducing anxiety limits the use of pharmacological agents, which increases patient safety.

Researchers will compare the use of relaxing soundscapes or virtual reality to the standard of care to see the effects of these strategies on pain, anxiety and stress.

Participants will:

  • listen to relaxing soundscapes, OR experience virtual reality including soundscapes OR standard of care during their procedure,
  • Answer pain, anxiety and recovery questionnaires,
  • Answer satisfaction questionnaires.
Read the detailed description

The EASY-HD project is a prospective, randomized, controlled pilot study to evaluate the effectiveness of immersive nonpharmacological strategies, soundscapes, and virtual reality (VR) on the reduction of intraprocedural anxiety and stress in patients undergoing a scheduled hemodynamic intervention (coronary angiography and/or angioplasty).

Adult patients will be included and randomized into three parallel groups (1:1:1): standard of care alone (control group), standard of care combined with relaxing soundscapes via headphones, or standard of care combined with virtual reality immersion in a soothing environment including sound. The devices will be set up 5 to 10 minutes before the procedure and continued througout.

This minimal-risk study aims to determine the feasibility and potential clinical benefit of these simple, reproducible non-pharmacological approaches to improve patient comfort and possibly reduce the need for hemodynamic sedation.

02

Conditions studied

  • Cardiovascular Disease
  • Cardiovascular Care
  • Pain and Anxiety During Cardiac Catheterization
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's planned enrollment of 60 is below the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Olivier F. Bertrand is the lead sponsor of 6 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults, 18 years or older
  • Scheduled hemodynamic intervention (coronary angiography and/or angioplasty)
  • Patient willing and able to understand the study
  • Signed informed consent

Exclusion criteria

Exclusion Criteria:

  • Scheduled complex procedure (CTO, structural)
  • Severe cognitive or psychiatric disorders
  • Major hearing/visual impairment
  • Severe motion sickness or history of malaise with Virtual Reality (VR)
  • Complaints of nausea or vomiting
  • History of epilepsy
  • Claustrophobia
  • Facial injuries
  • In clinical isolation (infection control)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • No intervention
    Control

    Standard of care analgesic and anxiolytic therapy

  • Experimental
    Auditive experience

    A pre-defined non-invasive audio experience using relaxing soundscapes via headphones will be used along standard of care pain and anxiety-relief medication (on patient's demand).

    Other: Auditive experience

  • Experimental
    Immersion experience

    A pre-defined virtual-reality led audiovisual experience will be used along standard of care pain and anxiety-relief medication (on patient's demand).

    Other: Audiovisual immersive experience

Interventions

  • OtherAuditive experience

    Auditive distraction therapy

  • OtherAudiovisual immersive experience

    Virtual reality-lead audiovisual experience

06

What researchers measure

Primary outcomes

  1. Change in patient-reported anxiety

    Change from baseline in patient reported anxiety evaluated by anxiety questionnaires Visual Analog Score for anxiety (0 = Not anxious at all - 10 = Extremely anxious)

    Time frame: Baseline (preprocedural), periprocedural and at one-week follow-up

  2. Change in patient-reported anxiety

    Change from baseline in patient reported anxiety evaluated by anxiety questionnaires State-Trait Anxiety Invetory for Adults - 6 item short form

    Time frame: Baseline, Periprocedural, and at one-week follow-up

  3. Change in patient-reported pain

    Change from baseline in patient reported pain evaluated by pain questionnaires Visual Analog Scale for pain (0=No pain - 10 = Worst pain possible)

    Time frame: Baseline, periprocedural and at one-week follow-up

Secondary outcomes

  1. Use of analgesic and anxiolytic medications

    Use vs no-use of analgesic (opioid/non-opioid) and/or anxiolytic medication. If analgesic and/or anxiolytic medication is used, its type, dose and frequency will be registered.

    Time frame: Within 48 hours before and after the procedure

  2. Change from baseline in physiological factors associated with pain and anxiety - Heart Rate

    Heart rate (beats per minute)

    Time frame: Baseline, periprocedural

  3. Change from baseline in physiological factors associated with pain and anxiety - Respiratory Rate

    Respiratory rate (breaths per minute)

    Time frame: Baseline, periprocedural

  4. Change from baseline in physiological factors associated with pain and anxiety - Blood Pressure

    Blood pressure (mmHg)

    Time frame: Baseline, Periprocedural

  5. Incidence of adverse events of interest

    Patient-reported nausea, dizziness and increased anxiety will be collected

    Time frame: Within 10 days of the procedure

Other outcomes

  1. Incidence of adverse cardiac events

    Time frame: Within 10 days of the procedure

07

Study locations

1 site
  • IUCPQ
    Québec, Quebec G1V 4G5, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07681180
Lead sponsor
Olivier F. Bertrand
Responsible party
Olivier F. Bertrand (MD, PhD, Laval University) — Sponsor-investigator
First posted
Jul 2, 2026
Start date
Aug 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Mar 2027 (estimated)
Last update
Jul 2, 2026

Study contacts

Michele Jadin
Contact
michele.jadin@criucpq.ulaval.ca
4186568711

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion